澳大利亚心肺移植受者非黑素瘤皮肤癌的发生频率与危险因素
该回顾性队列研究纳入94例澳大利亚心肺移植受者,随访发现61%发生移植后非黑素瘤皮肤癌,5年和10年累积概率分别为41%和67%。移植时年龄较大与NMSC风险增加相关,移植前皮肤癌史与基底细胞癌风险增加相关,Fitzpatrick III-VI型皮肤风险较低。建议对类似人群进行常规皮肤科监测。
要点
- 心肺移植受者非黑素瘤皮肤癌发生率高,10年累积概率达67%。
- 移植时年龄较大和移植前皮肤癌史是重要危险因素。
- Fitzpatrick III-VI型皮肤与NMSC风险降低相关。
核心结论
- 澳大利亚心肺移植受者中非黑素瘤皮肤癌发生频率可能较高,建议对类似人群进行频繁的常规皮肤科监测。
研究设计与样本
- 回顾性队列研究,在澳大利亚三级中心纳入94例心脏和/或肺移植后门诊皮肤科复查的连续患者。
主要发现
- 57例(61%)患者发生801例移植后皮肤癌。
- NMSC 5年累积概率41%(95%CI 31%-53%),10年67%(95%CI 55%-78%)。
- 基底细胞癌5年累积概率27%(95%CI 18%-38%),10年53%(95%CI 40%-67%)。
- 鳞状细胞癌5年累积概率33%(95%CI 24%-45%),10年62%(95%CI 50%-74%)。
临床怎么用
- 对心肺移植受者应定期进行皮肤科专科检查,尤其关注移植时年龄较大或有移植前皮肤癌史的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: There is limited research examining the incidence of nonmelanoma skin cancer (NMSC) in heart and lung transplant recipients in Australia. OBJECTIVE: To determine the frequency of and risk factors for NMSC in a cohort of Australian heart and lung transplant recipients. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study was conducted at an Australian tertiary center where heart and lung transplants are performed between March 21 and December 14, 2016. A consecutive sample of 94 patients who underwent heart and/or lung transplant presenting for outpatient dermatologic review were evaluated. Data analysis was conducted between April 18 and October 30, 2017. EXPOSURES: Risk factors examined for association with posttransplantation NMSC included age at the time of transplantation, sex, skin phenotype, UV radiation exposure, history of allograft rejection, history of smoking, history of skin cancer prior to transplant, and transplant type. MAIN OUTCOMES AND MEASURES: The primary outcome measure was the occurrence of posttransplantation NMSC. The probabilities of developing NMSC in general, and squamous cell carcinoma and basal cell carcinoma specifically, were separately summarized based on Kaplan-Meier analysis. Association of risk factors with development of NMSC was examined using univariable and multivariable Cox proportional hazards regression analysis. RESULTS: Of the 94 study participants, 58 (62%) were men; median age at transplantation was 51.9 years (range, 15.1-69.7 years). There were 801 posttransplantation skin cancers in 57 (61%) of the patients who underwent heart and/or lung transplant. The probabilities for NMSC were 41% (95% CI, 31%-53%) at 5 years and 67% (95% CI, 55%-78%) at 10 years; for basal cell carcinoma, 27% (95% CI, 18%-38%) at 5 years and 53% (95% CI, 40%-67%) at 10 years; and for squamous cell carcinoma, 33% (95% CI, 24%-45%) at 5 years and 62% (95% CI, 50%-74%) at 10 years. On multivariable analysis, older age at transplantation was associated with the development of NMSC (hazard ratio [HR], 1.07/1 year; 95% CI, 1.04-1.10; P < .001) and history of pretransplant skin cancer was associated with development of basal cell carcinoma (HR, 4.56; 95% CI, 1.67-12.42; P = .003). A Fitzpatrick skin type III to VI was associated with a decreased risk of NMSC (HR, 0.42; 95% CI, 0.24-0.74; P = .003). Sex, transplanted organ, UV radiation exposure, and history of allograft rejection were not associated with an increased risk of skin cancer. CONCLUSIONS AND RELEVANCE: In this study of Australian heart and lung transplant recipients, there was a probable high frequency of NMSC. Routine dermatologic surveillance at frequent intervals is advised for similar populations.
引用
- De Rosa N, Paddon VL, Liu Z, et al. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients. JAMA Dermatol. 2019. PMID: 30865218. doi:10.1001/jamadermatol.2018.4789
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。